Press release
Idiopathic Membranous Nephropathy Market Size is estimated to grow with a significant CAGR during the study period (2020-2034).
DelveInsight's "Idiopathic Membranous Nephropathy Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Idiopathic Membranous Nephropathy (IMN), historical and forecasted epidemiology as well as the Idiopathic Membranous Nephropathy (IMN) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Discover Key Insights into the Idiopathic Membranous Nephropathy Market with DelveInsight's In-Depth Report @ Idiopathic Membranous Nephropathy Market Size [https://www.delveinsight.com/sample-request/idiopathic-membranous-nephropathy-imn-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Idiopathic Membranous Nephropathy Market Report
* In November 2024:- National Institute of Allergy and Infectious Diseases (NIAID)- The primary objective of this study is to evaluate the effectiveness of belimumab and intravenous rituximab co-administration at inducing a complete or partial remission (CR or PR) compared to rituximab alone in participants with primary membranous nephropathy.
* In 2023, the US accounted for ~40% of all Idiopathic Membranous Nephropathy prevalent cases in 7MM.
* Japan's data suggests a relatively stable trend in the Idiopathic Membranous Nephropathy prevalence over the forecasted period of 2024-2034.
* Germany had the highest Idiopathic Membranous Nephropathy prevalence among EU4 and the UK, accounting for ~30% of cases, followed by the UK with ~20%, in 2023.
* In 2023, the PLA2R-specific cases in EU4 and the UK contributed ~75% in the 7MM.
* The leading Idiopathic Membranous Nephropathy Companies such as SynAct Pharma Aps, argenx, Shanghai Jiaolian Drug Research and Development Co., Ltd, Beijing Mabworks Biotech Co., Ltd., Cerium Pharmaceuticals, Inc., BeiGene, Reistone Biopharma Company Limited, Hoffmann-La Roche, Alpine Immune Sciences, Inc., Walden Biosciences , and others.
* Promising Idiopathic Membranous Nephropathy Therapies such as WAL0921, povetacicept, Belimumab, Obinutuzumab, Methylprednisolone, Tacrolimus , and others.
Stay ahead in the Idiopathic Membranous Nephropathy Therapeutics Market with DelveInsight's Strategic Report @ Idiopathic Membranous Nephropathy Market Outlook [https://www.delveinsight.com/sample-request/idiopathic-membranous-nephropathy-imn-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Idiopathic Membranous Nephropathy Epidemiology Segmentation in the 7MM
* Total Idiopathic Membranous Nephropathy prevalent cases
* Idiopathic Membranous Nephropathy antigen-specific cases
* Total Idiopathic Membranous Nephropathy treated cases
Download the report to understand which factors are driving Idiopathic Membranous Nephropathy epidemiology trends @ Idiopathic Membranous Nephropathy Prevalence [https://www.delveinsight.com/sample-request/idiopathic-membranous-nephropathy-imn-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Idiopathic Membranous Nephropathy Market Insights
Membranous nephropathy (MN) is an autoimmune disease caused by antibodies mostly directed to podocyte antigens and characterized by very high levels of protein in the urine, edema, hypoalbuminemia, and elevated serum lipids. MN is typically divided into primary MN (Idiopathic membranous nephropathy) when there is no underlying disease association and secondary MN when there is an underlying disease association such as autoimmune disease (most commonly lupus), malignancy, infection, or temporal association with the use of certain drugs. The short-term goal of treatment is to stop protein spillage completely (known as remission) or lower the amount of protein lost in the urine as much as possible. The less protein lost in the urine, the better the individual will do. The long-term treatment goals, including protein relapses in the urine and preventing the deterioration of kidney function.
Idiopathic Membranous Nephropathy Emerging Drugs
* GAZYVA (obinutuzumab): Hoffmann-La Roche
* SNP-ACTH (1-39) Gel: Cerium Pharmaceuticals
Get In-Depth Knowledge on Idiopathic Membranous Nephropathy Market Trends and Forecasts with DelveInsight @ Idiopathic Membranous Nephropathy Treatment Market [https://www.delveinsight.com/sample-request/idiopathic-membranous-nephropathy-imn-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Idiopathic Membranous Nephropathy Drugs Uptake
Idiopathic Membranous Nephropathy pipeline possesses some drugs in mid- and late stage developments to be approved in the near future. Expected launch of emerging therapies, such as GAZYVA (obinutuzumab) by Hoffmann-La Roche, MOR202 (felzartamab) by MorphoSys/HI-Bio, MOR202 (felzartamab) by MorphoSys/HI-Bio, BRUKINSA (zanubrutinib) by BeiGene and others shall further create a positive impact on the market.
Scope of the Idiopathic Membranous Nephropathy Market Report
* Coverage- 7MM
* Idiopathic Membranous Nephropathy Companies- SynAct Pharma Aps, argenx, Shanghai Jiaolian Drug Research and Development Co., Ltd, Beijing Mabworks Biotech Co., Ltd., Cerium Pharmaceuticals, Inc., BeiGene, Reistone Biopharma Company Limited, Hoffmann-La Roche, Alpine Immune Sciences, Inc., Walden Biosciences, and others.
* Idiopathic Membranous Nephropathy Therapies- WAL0921, povetacicept, Belimumab, Obinutuzumab, Methylprednisolone, Tacrolimus, and others.
* Idiopathic Membranous Nephropathy Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
* Idiopathic Membranous Nephropathy Unmet Needs, KOL's views, Analyst's views, Idiopathic Membranous Nephropathy Market Access and Reimbursement
Unlock Strategic Insights with DelveInsight's Comprehensive Idiopathic Membranous Nephropathy Market Report @ Idiopathic Membranous Nephropathy Market Drivers and Barriers [https://www.delveinsight.com/sample-request/idiopathic-membranous-nephropathy-imn-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Report Introduction
3. Idiopathic Membranous Nephropathy (IMN) Market Overview at a Glance
4. Methodology
5. Executive Summary of IMN
6. Key Events
7. Disease Background and Overview
8. Treatment and Management
9. Epidemiology and Patient Population
10. Patient Journey
11. Emerging Therapies
12. Market Analysis
13. KOL Views
14. SWOT Analysis
15. Unmet Needs
16. Market Access and Reimbursement
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=idiopathic-membranous-nephropathy-market-size-is-estimated-to-grow-with-a-significant-cagr-during-the-study-period-20202034]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Membranous Nephropathy Market Size is estimated to grow with a significant CAGR during the study period (2020-2034). here
News-ID: 3736603 • Views: …
More Releases from ABNewswire
Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repai …
Water Fire Mold Damage Service, a trusted provider of property restoration, has announced expanded service offerings to meet the growing demand for professional water damage solutions in the region. Known for their reliable, customer-focused approach, the company continues to support both homeowners and businesses in recovering from unexpected property damage caused by water, fire, or mold.
Responding to a Growing Need for Water Damage Restoration
Property owners across Minnesota are increasingly seeking…
Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Inju …
For individuals searching for personal injury attorneys, the expansion of Winkler Kurtz LLP's team means greater accessibility and reduced wait times for consultations. The firm's deep roots in the Port Jefferson Station community allow them to understand local nuances, such as common accident hotspots and specific regional legal precedents.
Port Jefferson Station has seen a notable rise in personal injury cases, driven by factors such as increased traffic congestion, construction activity,…
Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washi …
For residents searching for power washing near me, Hose Bros Inc offers accessible and reliable services tailored to the Millsboro community. Their local expertise ensures an understanding of regional challenges, such as the impact of salt air on coastal properties or the tendency for humidity to promote mold growth in shaded areas. This knowledge allows them to customize their approach, selecting appropriate pressure levels and cleaning agents for different surfaces.
In…
![Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Prices](https://cdn.open-pr.com/9/1/914818326_g.jpg)
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Price …
A 2025 cost guide to kitchen, bathroom, and full home remodeling in Tampa Bay, featuring expert insights from Craftline Remodeling on pricing, budgeting, and contractor selection.
Market Overview: Understanding Tampa Bay Remodeling Investment Trends
Tampa Bay's home remodeling market has experienced significant cost evolution in 2025, with project expenses varying dramatically across South Tampa, Carrollwood, Seminole Heights, Clearwater, St. Petersburg, and Wesley Chapel based on material choices, project scope, and contractor expertise.…
More Releases for Idiopathic
Idiopathic Pulmonary Fibrosis Market Size & Share Analysis
The new report published by The Business Research Company, titled Idiopathic Pulmonary Fibrosis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the idiopathic pulmonary fibrosis market size has grown strongly in recent years. It will grow from $3.89…
Idiopathic Pulmonary Fibrosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Idiopathic Pulmonary Fibrosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,…
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth …
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria).
R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. In…
Global Idiopathic Scoliosis Treatment Market Size by Type (Infantile Idiopathic, …
Global Idiopathic Scoliosis Treatment Market Research report provides vital information related to the overall market and forecast from 2019 to 2026. This report includes the in-depth analysis of market size, share, growth, trends and regional demand and top layers the Idiopathic Scoliosis Treatment Market. The major players dominating the market are focused upon throughout the by analyzing their revenue, their business summary, product segmentation along with the latest developments.
Get Sample…
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation…
